ALNA®

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Prostatic Hyperplasia

Unknown Phase

Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia

CompletedNCT02244268

Boehringer IngelheimProstatic Hyperplasia

Start: 2000-10-31Updated: 2014-09-19

Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)

CompletedNCT02244333

Boehringer IngelheimProstatic Hyperplasia

Start: 2004-02-29Updated: 2014-09-19